| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | interleukin-17 receptor activity | 1.28e-05 | 8 | 14 | 2 | GO:0030368 | |
| GeneOntologyMolecularFunction | protein tyrosine/serine/threonine phosphatase activity | 4.05e-04 | 43 | 14 | 2 | GO:0008138 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.58e-03 | 85 | 14 | 2 | GO:0017018 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 2.05e-03 | 97 | 14 | 2 | GO:0004896 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 2.30e-03 | 103 | 14 | 2 | GO:0004725 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 2.57e-03 | 109 | 14 | 2 | GO:0004722 | |
| GeneOntologyMolecularFunction | immune receptor activity | 5.79e-03 | 165 | 14 | 2 | GO:0140375 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 7.52e-03 | 189 | 14 | 2 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.67e-02 | 287 | 14 | 2 | GO:0016791 | |
| Domain | SEFIR | 7.81e-06 | 6 | 14 | 2 | PF08357 | |
| Domain | SEFIR_dom | 7.81e-06 | 6 | 14 | 2 | IPR013568 | |
| Domain | SEFIR | 7.81e-06 | 6 | 14 | 2 | PS51534 | |
| Domain | DUSP | 2.40e-04 | 31 | 14 | 2 | IPR024950 | |
| Domain | TYR_PHOSPHATASE_DUAL | 2.89e-04 | 34 | 14 | 2 | PS50054 | |
| Domain | DSPc | 3.06e-04 | 35 | 14 | 2 | SM00195 | |
| Domain | TYR_PHOSPHATASE_DUAL_dom | 3.06e-04 | 35 | 14 | 2 | IPR020422 | |
| Domain | SOCS_box | 3.61e-04 | 38 | 14 | 2 | PF07525 | |
| Domain | SOCS_box | 3.81e-04 | 39 | 14 | 2 | SM00969 | |
| Domain | SOCS_box | 3.81e-04 | 39 | 14 | 2 | IPR001496 | |
| Domain | SOCS | 3.81e-04 | 39 | 14 | 2 | PS50225 | |
| Domain | Dual-sp_phosphatase_cat-dom | 4.21e-04 | 41 | 14 | 2 | IPR000340 | |
| Domain | DSPc | 4.21e-04 | 41 | 14 | 2 | PF00782 | |
| Domain | TYR_PHOSPHATASE_1 | 1.84e-03 | 86 | 14 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.88e-03 | 87 | 14 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.88e-03 | 87 | 14 | 2 | IPR000387 | |
| Domain | - | 2.10e-03 | 92 | 14 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.43e-03 | 99 | 14 | 2 | IPR029021 | |
| Domain | Ank_2 | 1.10e-02 | 215 | 14 | 2 | PF12796 | |
| Domain | Ank | 1.23e-02 | 228 | 14 | 2 | PF00023 | |
| Domain | - | 1.44e-02 | 248 | 14 | 2 | 1.25.40.20 | |
| Domain | ANK | 1.47e-02 | 251 | 14 | 2 | SM00248 | |
| Domain | ANK_REPEAT | 1.49e-02 | 253 | 14 | 2 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.51e-02 | 254 | 14 | 2 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.51e-02 | 254 | 14 | 2 | PS50297 | |
| Domain | Ankyrin_rpt | 1.60e-02 | 262 | 14 | 2 | IPR002110 | |
| Pathway | WP_IL17_SIGNALING | 3.25e-04 | 32 | 12 | 2 | M39560 | |
| Pubmed | IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis. | 6.24e-06 | 9 | 15 | 2 | 27956525 | |
| Pubmed | 1.35e-05 | 13 | 15 | 2 | 30824326 | ||
| Pubmed | ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. | 2.35e-05 | 17 | 15 | 2 | 16325183 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 7.39e-05 | 1105 | 15 | 5 | 35748872 | |
| Pubmed | 1.41e-04 | 41 | 15 | 2 | 12076535 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 1.71e-03 | 189 | 15 | 2 | chr10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 8.21e-03 | 423 | 15 | 2 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 9.41e-03 | 454 | 15 | 2 | chr11q13 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.86e-04 | 42 | 11 | 2 | 602 | |
| GeneFamily | Ankyrin repeat domain containing | 9.06e-03 | 242 | 11 | 2 | 403 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.50e-05 | 174 | 15 | 3 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.46e-05 | 194 | 15 | 3 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.65e-04 | 96 | 15 | 2 | bf62c29da66aa3eefdc59337dfb3cd0467f04f10 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.65e-04 | 96 | 15 | 2 | d98df92856840602a82d3f050bf0a1543445cac0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.77e-04 | 107 | 15 | 2 | d4807f008619dfd3e215d602df0d02b135b1ac37 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.77e-04 | 107 | 15 | 2 | 5907b9632c88d48f293c3c6d37b7ef831fbcdd86 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.77e-04 | 107 | 15 | 2 | 3f24de1afbfd070f9db11c9acd02b90e5eb2511d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.31e-04 | 112 | 15 | 2 | 518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.73e-04 | 124 | 15 | 2 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.23e-04 | 128 | 15 | 2 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.01e-04 | 134 | 15 | 2 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.42e-04 | 137 | 15 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-04 | 138 | 15 | 2 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-03 | 144 | 15 | 2 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-03 | 145 | 15 | 2 | c0894c738815ff54790caddb4bccfa1503fd555b | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-03 | 146 | 15 | 2 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 151 | 15 | 2 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-03 | 152 | 15 | 2 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-03 | 152 | 15 | 2 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 153 | 15 | 2 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 153 | 15 | 2 | 98670bbce4a770af244f033cdd2d54db57200ca8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 154 | 15 | 2 | f29316d4b4dcdb23bd427d78068e65a9802f7f07 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 154 | 15 | 2 | 66065c0763c83d98084ca6969694c3af37e43274 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-5|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.25e-03 | 158 | 15 | 2 | 34b284a62cc3fb90429ce579fd8cb8a60178091b | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 1.28e-03 | 160 | 15 | 2 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 1.28e-03 | 160 | 15 | 2 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-03 | 161 | 15 | 2 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.31e-03 | 162 | 15 | 2 | 0e8fb83acb8ea9905cc3ca985feb8a00931549ff | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-03 | 162 | 15 | 2 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-03 | 164 | 15 | 2 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-03 | 164 | 15 | 2 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 1.34e-03 | 164 | 15 | 2 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-03 | 164 | 15 | 2 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 165 | 15 | 2 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-03 | 167 | 15 | 2 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-03 | 167 | 15 | 2 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 1.43e-03 | 169 | 15 | 2 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.43e-03 | 169 | 15 | 2 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 172 | 15 | 2 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-03 | 176 | 15 | 2 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.56e-03 | 177 | 15 | 2 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-03 | 179 | 15 | 2 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-03 | 180 | 15 | 2 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.63e-03 | 181 | 15 | 2 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.65e-03 | 182 | 15 | 2 | bb1f815718397de96682697fcbd6014a992a28f7 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.65e-03 | 182 | 15 | 2 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.65e-03 | 182 | 15 | 2 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-03 | 182 | 15 | 2 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 1.70e-03 | 185 | 15 | 2 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.76e-03 | 188 | 15 | 2 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 1.78e-03 | 189 | 15 | 2 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 1.82e-03 | 191 | 15 | 2 | 7a28905ad504979497836e87df81d529e675ce78 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.82e-03 | 191 | 15 | 2 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-03 | 191 | 15 | 2 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-03 | 191 | 15 | 2 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | COVID-19_Mild-MAIT|COVID-19_Mild / Disease condition and Cell class | 1.82e-03 | 191 | 15 | 2 | e834d7a6aa7bb4f194b203d351e53bf5d95175d6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.82e-03 | 191 | 15 | 2 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 192 | 15 | 2 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 192 | 15 | 2 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 193 | 15 | 2 | 44ba79db566d0fa3bbcfe3adf9164bf8c3cb0bc3 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.85e-03 | 193 | 15 | 2 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 193 | 15 | 2 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | Control-MAIT|Control / Disease condition and Cell class | 1.87e-03 | 194 | 15 | 2 | ed99f8bff6766795fc396990604366f49ff58181 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.89e-03 | 195 | 15 | 2 | 59164d115a0928cc9b79c7661c7190ad695f9d80 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.89e-03 | 195 | 15 | 2 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.89e-03 | 195 | 15 | 2 | e173a713d273b135db4f71bdcaada3b0e55d74f1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-03 | 195 | 15 | 2 | c7b54b210cc2c8ddaefebfba74381adb2ca698b8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-03 | 195 | 15 | 2 | a8fd42ff6c2bd80d0e3f20fe3bbf7d113b399df1 | |
| ToppCell | (1)_T_CD8_MAIT|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.91e-03 | 196 | 15 | 2 | 5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e | |
| ToppCell | (1)_T_cells-(1)_T_CD8_MAIT|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.93e-03 | 197 | 15 | 2 | 0f01907d62c9c08cb54fe66c038f0adf7093e3c6 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-03 | 198 | 15 | 2 | 5bdffabf80716dd80c1265c3d126c7a25340251c | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 1.95e-03 | 198 | 15 | 2 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-03 | 198 | 15 | 2 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.99e-03 | 200 | 15 | 2 | fe15fb050852c187f6f17fb4f6172e69fe7d74a4 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-03 | 200 | 15 | 2 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.99e-03 | 200 | 15 | 2 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuroepithelial-Proteoglycan-expressing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.99e-03 | 200 | 15 | 2 | d0a4c3bf9c5211defb4c1d0b6653833cccbd29ee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.99e-03 | 200 | 15 | 2 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-03 | 200 | 15 | 2 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | Control-Control-Lymphocyte-T/NK-MAIT|Control / Disease, condition lineage and cell class | 1.99e-03 | 200 | 15 | 2 | 888a8045e0457cd9d0c570360cca20a6efb44f13 | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.35e-06 | 193 | 15 | 4 | 4286_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 6.48e-06 | 194 | 15 | 4 | 4001_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 7.03e-06 | 198 | 15 | 4 | 2345_UP |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLRLLPPELLRQLFP | 46 | Q7Z5W3 | |
| LRYPPQSPRRLRMLL | 441 | P43353 | |
| PRLPLPPRLLRYLQL | 446 | Q8WXI3 | |
| ATRLPLPPLLRDYLL | 431 | Q96NS5 | |
| YERALRLLRLPQLPP | 91 | Q9UGP5 | |
| RPGRRPLRLLYLCPA | 521 | Q6UXK2 | |
| PLLEALRLYARRRRP | 356 | P13631 | |
| ALPRERLRPRPKVFL | 346 | Q8NFM7 | |
| PLRALPRYRLLRDLP | 606 | Q8NFR9 | |
| PRYRLLRDLPRLLRA | 611 | Q8NFR9 | |
| REDPPRLLFPRLSLL | 166 | Q4VX62 | |
| LRRELSPPRPRLLLL | 11 | Q99956 | |
| RLFLLEPPGPDRLRL | 3281 | Q5T011 | |
| SLRELLRLPLRYPRA | 211 | Q9BVQ7 | |
| LLLPYPRARARLPRD | 36 | Q9UK23 | |
| QLEAPRPPRLRYLLV | 116 | Q8TE77 | |
| LRLLLLLGYRRRCPP | 16 | Q969W1 |